Research has confirmed that women who undergo menopause before age 45 are at an increased risk of heart failure, cardiovascular disease and other conditions. Now, a link has recently been reported between late menopause and heart failure – with an important role for obesity.
In a collaborative effort co-led by teams from Vanderbilt University Medical Center (VUMC) and the University of Michigan, a comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes.
Alvin C. Powers, MD, Joe C. Davis Professor of Biomedical Science and professor of Medicine, Molecular Physiology and Biophysics, has received the 2023 William S. Middleton Award, the highest honor awarded by the Department of Veterans Affairs (VA) Biomedical Laboratory Research and Development Service.
A team of surgeons and biomedical engineers at Vanderbilt University Medical Center and Vanderbilt University (VU) have shown the use of probe-based near infrared autofluorescence (NIRAF) technology helps confirm the identification of parathyroid glands during endocrine surgery, and their findings are part of a multisite trial of the technology now underway.
A multisite, international phase 2 trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation in patients with fibrodysplasia ossificans progressiva (FOP).
Alvin C. Powers, MD, Joe C. Davis Professor of Biologic Science and professor of Medicine, Molecular Physiology and Biophysics, has announced plans to step down effective July 1, 2024, as director of the Vanderbilt Diabetes Center (VDC), director of the Vanderbilt Diabetes Research and Training Center (DRTC), and chief of the Vanderbilt Division of Diabetes, Endocrinology and Metabolism at Vanderbilt University Medical Center.
